MD Anderson’s Moon Shots Program is an unprecedented, comprehensive assault to significantly reduce cancer deaths and transform cancer care. Moon shot teams pursue innovative projects prioritized for greatest patient impact, including groundbreaking clinical trials of new cancer immunotherapies, targeted therapies and combinations. Longer-term collaboration to heighten molecular understanding of cancers and therapies aims to further improve translational research and move scientific findings into the clinic. Many moon shots also include prevention and early detection projects. Specialized platforms provide infrastructure, systems and strategy.
The ultimate goal is to apply knowledge gained from this process to all cancers. Moon shot efforts will help support all other cancer research at MD Anderson, particularly with improved resources and infrastructure. Funding is from private philanthropy, institutional earnings, competitive research grants and commercialization of new discoveries.
12 areas of focus:
- Acute myeloid leukemia/myelodysplastic syndromes
- B-cell lymphoma
- Chronic lymphocytic leukemia
- Colorectal cancer
- High-risk multiple myeloma
- Human papillomavirus-related cancers
- Lung cancer
- Pancreatic cancer
- Prostate cancer
- Triple negative breast and high-grade serous ovarian cancers
As of Feb. 29, private philanthropic commitments to the program total more than $348.3 million.